News
Noxxea in « Les Échos » December 2025
We are extremely proud to see Noxxea highlighted in Les Échos.
For a young digital health solution like ours, it’s far more than just an article : it’s true recognition.
Noxxea exists to address a powerful and often silent need:
to help those who can’t sleep, who suffer from chronic insomnia, who are looking for an effective solution without dependency, without medication, grounded in science and built around people.
Official launch of NOXXEA – 100% French CBT-I - November 2025
We were very happy to attend the 2025 SFRMS Congress, one of the key events in sleep medicine in France. After several years of development, NOXXEA is now becoming the first 100% French digital therapy fully compliant with CBT-I, and is now available for prescription.A huge thank you to all our partners involved in the development of the IKOMOBI application — Iris Production Groupe, Réseau Morphée, and NEX&COM Agency for their support with the communication for the booth.
And of course, our warmest thanks to our scientific committee for their commitment, expertise, and trust throughout this project.
Noxxea Wins the Scientific Committee Prize at Encéphale congress - January 2025
We are honored to receive the Scientific Committee Prize at the
2025 Encéphale Congress. This recognition highlights key milestones for our unique model of digital medicines, fully dedicated to sleep disorders. After several years of development, our solution, Noxxea, has emerged as the first 100% digital and personalized treatment for insomnia, based on the principles of Cognitive Behavioral
Therapy (CBT).
Di&Care and Noxxea at the Encéphale Congress - January 2025
In January 2025, Di&Care and Noxxea participated in the prestigious Encéphale Congress, a leading event in the field of mental health and psychiatry.
Meeting of the Di&Care Scientific Committee - January 2025
As every year, Di&Care brought together its scientific committee, composed of sleep specialists, psychiatrists, and generalpractitioners. This enriching day of discussions aims to advance our programs, with the constant goal of offering innovative and personalized solutions for patients.
Di&Care, Winner of the CIC Business Award
In December 2024, Di&Care was honored at the CIC Business Award in Lille for its model of digital medicines in mental health, marking a significant milestone in the development of our company.
Noxxea showcased at the SFMRS - November 2024
Noxxea made its first appearance at the French Society of Sleep Medicine, marking a crucial milestone in increasing its visibility. Noxxea is the first 100% digital and French treatment for insomnia.
Pépite Award Hodéfi - September 2024
Di&Care was honored with the Pépite Award, a distinction that supports innovative and creative business creation projects. Hodéfi, founded in 1983 by the Grand Lille Chamber of Commerce and Industry, has been supporting businesses for over 30 years, specializing in innovation.